These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32647289)

  • 1. Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases.
    Li B; Wang R; Zhang T; Sun X; Jiang C; Li W; Zou B; Xie P; Meng X; Sun X; Wang L; Yu J
    Sci Rep; 2020 Jul; 10(1):11259. PubMed ID: 32647289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
    Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic evaluation of esophageal cancer patients with stages I-III.
    Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
    Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.
    Goense L; Merrell KW; Arnett AL; Hallemeier CL; Meijer GJ; Ruurda JP; Hofstetter WL; van Hillegersberg R; Lin SH
    Ann Thorac Surg; 2018 Nov; 106(5):1541-1547. PubMed ID: 29932887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
    Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of prognostic nomogram based on the SEER database for esophageal cancer patients.
    Cao X; Wu B; Guo S; Zhong W; Zhang Z; Li H
    Clinics (Sao Paulo); 2024; 79():100433. PubMed ID: 39079460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy.
    Du XX; Yu R; Wang ZF; Du DC; Liu QY; Wang RM; Kang SR; Yang H
    Bosn J Basic Med Sci; 2019 May; 19(2):186-194. PubMed ID: 30877837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A prognostic nomogram for metastasized colorectal cancer patients treated with cetuximab].
    Zhong LP; Li D; Zhu LZ; Fang XF; Xiao Q; Ding KF; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):701-708. PubMed ID: 32683833
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of nomogram based on pre-treatment inflammatory markers in patients with pulmonary-only synchronous metastases from colorectal cancer.
    Chen L; Li Q; Wang Y; Yang J; Ma X
    Int Immunopharmacol; 2019 Dec; 77():106001. PubMed ID: 31734191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
    Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer.
    Yang YJ; Lin GW; Li GX; Dai B; Ye DW; Wu JL; Xie HY; Zhu Y
    Asian J Androl; 2018; 20(2):184-188. PubMed ID: 29111539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
    van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
    Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer.
    Xu J; Lu D; Zhang L; Li J; Sun G
    Cancer Med; 2019 Dec; 8(17):7253-7264. PubMed ID: 31612596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
    Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
    J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy.
    Previs RA; Bevis KS; Huh W; Tillmanns T; Perry L; Moore K; Chapman J; McClung C; Kiet T; Java J; Chan J; Secord AA
    Gynecol Oncol; 2014 Mar; 132(3):531-6. PubMed ID: 24472410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.
    Rose PG; Java J; Whitney CW; Stehman FB; Lanciano R; Thomas GM; DiSilvestro PA
    J Clin Oncol; 2015 Jul; 33(19):2136-42. PubMed ID: 25732170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.
    Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM
    World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
    Bütof R; Hofheinz F; Zöphel K; Stadelmann T; Schmollack J; Jentsch C; Löck S; Kotzerke J; Baumann M; van den Hoff J
    J Nucl Med; 2015 Aug; 56(8):1150-6. PubMed ID: 26089549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease.
    Tanadini-Lang S; Rieber J; Filippi AR; Fode MM; Streblow J; Adebahr S; Andratschke N; Blanck O; Boda-Heggemann J; Duma M; Eble MJ; Ernst I; Flentje M; Gerum S; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lohaus F; Petersen C; Schrade E; Wendt TG; Wittig A; Høyer M; Ricardi U; Sterzing F; Guckenberger M
    Radiother Oncol; 2017 May; 123(2):182-188. PubMed ID: 28169042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.
    Giordano A; Egleston BL; Hajage D; Bland J; Hortobagyi GN; Reuben JM; Pierga JY; Cristofanilli M; Bidard FC
    Clin Cancer Res; 2013 Mar; 19(6):1596-602. PubMed ID: 23340302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.